Academia.eduAcademia.edu

Outline

Title
Abstract
Introduction
Patient-Specific Risk Factors
Conclusions
References
All Topics
Medicine and Health Sciences
Pharmacology

Kidney-based in vitro models for drug-induced toxicity testing

Profile image of Silvia MihailaSilvia Mihaila

2019, Archives of Toxicology

https://doi.org/10.1007/S00204-019-02598-0
visibility

…

description

22 pages

link

1 file

Abstract

The kidney is frequently involved in adverse effects caused by exposure to foreign compounds, including drugs. An early prediction of those effects is crucial for allowing novel, safe drugs entering the market. Yet, in current pharmacotherapy, drug-induced nephrotoxicity accounts for up to 25% of the reported serious adverse effects, of which one-third is attributed to antimicrobials use. Adverse drug effects can be due to direct toxicity, for instance as a result of kidney-specific determinants, or indirectly by, e.g., vascular effects or crystals deposition. Currently used in vitro assays do not adequately predict in vivo observed effects, predominantly due to an inadequate preservation of the organs' microenvironment in the models applied. The kidney is highly complex, composed of a filter unit and a tubular segment, together containing over 20 different cell types. The tubular epithelium is highly polarized, and the maintenance of this polarity is critical for optimal functioning and response to environmental signals. Cell polarity is dependent on communication between cells, which includes paracrine and autocrine signals, as well as biomechanic and chemotactic processes. These processes all influence kidney cell proliferation, migration, and differentiation. For drug disposition studies, this microenvironment is essential for prediction of toxic responses. This review provides an overview of drug-induced injuries to the kidney, details on relevant and translational biomarkers, and advances in 3D cultures of human renal cells, including organoids and kidney-on-a-chip platforms.

Related papers

Human Kidney Proximal Tubule-On-A-Chip for Drug Trans- Porter Studies and Nephrotoxicity Assessment
Donald Ingber

2011

We introduce a simple microfluidic device that mimics function of the kidney proximal tubule by integrating a polydimethylsiloxane (PDMS) microfluidic channel and human proximal tubule cells on a porous extracellular matrix (ECM)coated porous membrane. This allows us to culture the kidney epithelial cells under a low level (0.2 dyne/cm 2 ) of fluid shear stress that mimics that of the normal kidney tubule. By providing in this system, a more physiological microenvironment, we are able to enhance epithelial cell polarization, cytoskeletal reorganization, primary cilia formation and response to renal toxins. These results suggest that our system is useful for studying human-relevant renal toxicity, and has the potential for drug development and advanced tissue engineering applications.

View PDFchevron_right
Drug-Induced Nephrotoxicity: Mechanistic Insights and Emerging Therapeutic Strategies
IRJPMS Editor

IRJPMS, 2025

Drug-induced nephrotoxicity is a significant contributor to acute and chronic kidney injury in clinical and preclinical settings. This review provides an integrative overview of the diverse pathophysiological mechanisms underlying DIN, including hemodynamic al terations, direct tubular toxicity, crystal nephropathy, thrombotic microangiopathy, rhabdomyolysis, interstitial nephritis, and glomeru lonephritis. Evidence from human studies and animal models (primarily rodents) is synthesized, highlighting how various drugs disrupt rena l structure and function. A comprehensive table categorizes nephrotoxic agents, their mechanisms, pathological changes, and clinical manifest ations. Both herbal and synthetic treatments are reviewed in rat and human models. Furthermore, this review explores novel therapeutic str ategies, including mitochondria-targeted therapy, regenerative medicine with stem cell approaches, RNA-based interventions, artificial intelligence, and machine learning for predictive modeling, and the development of kidney-on-a-chip systems. The new technologies would provide successful approaches to detect nephrotoxicity early and understand pharmaceutical mechanisms while delivering individualized care, whic h minimizes traditional animal testing needs and boosts drug development translation .

View PDFchevron_right
Development and Application of Human Renal Proximal Tubule Epithelial Cells for Assessment of Compound Toxicity
Ruili Huang

Current chemical genomics and translational medicine, 2017

Kidney toxicity is a major problem both in drug development and clinical settings. It is difficult to predict nephrotoxicity in part because of the lack of appropriate in vitro cell models, limited endpoints, and the observation that the activity of membrane transporters which plays important roles in nephrotoxicity by affecting the pharmacokinetic profile of drugs is often not taken into account. We developed a new cell model using pseudo-immortalized human primary renal proximal tubule epithelial cells. This cell line (SA7K) was characterized by the presence of proximal tubule cell markers as well as several functional properties, including transporter activity and response to a few well-characterized nephrotoxicants. We subsequently evaluated a group of potential nephrotoxic compounds in SA7K cells and compared them to a commonly used human immortalized kidney cell line (HK-2). Cells were treated with test compounds and three endpoints were analyzed, including cell viability, apo...

View PDFchevron_right
Sensitive , Early Detection of Kidney Toxicity in Preclinical Drug Safety MILLIPLEX ® map Rat Kidney Toxicity Multiplex Panels Measure Urinary Biomarkers of Kidney Injury
Lothar Goretzki

2011

View PDFchevron_right
Implementation of a Human Renal Proximal Tubule on a Chip for Nephrotoxicity and Drug Interaction Studies
Frans Russel

Journal of Pharmaceutical Sciences, 2021

Proximal tubule epithelial cells (PTEC) are susceptible to drug-induced kidney injury (DIKI). Cell-based, two-dimensional (2D) in vitro PTEC models are often poor predictors of DIKI, probably due to the lack of physiological architecture and flow. Here, we assessed a high throughput, 3D microfluidic platform (Nephroscreen) for the detection of DIKI in pharmaceutical development. This system was established with four model nephrotoxic drugs (cisplatin, tenofovir, tobramycin and cyclosporin A) and tested with eight pharmaceutical compounds. Measured parameters included cell viability, release of lactate dehydrogenase (LDH) and N-acetyl-b-D-glucosaminidase (NAG), barrier integrity, release of specific miRNAs, and gene expression of toxicity markers. Drug-transporter interactions for P-gp and MRP2/4 were also determined. The most predictive read outs for DIKI were a combination of cell viability, LDH and miRNA release. In conclusion, Nephroscreen detected DIKI in a robust manner, is compatible with automated pipetting, proved to be amenable to long-term experiments, and was easily transferred between laboratories. This proof-of-concept-study demonstrated the usability and reproducibility of Nephroscreen for the detection of DIKI and drug-transporter interactions. Nephroscreen it represents a valuable tool towards replacing animal testing and supporting the 3Rs (Reduce, Refine and Replace animal experimentation).

View PDFchevron_right
Preparation of positional renal slices for study of cell-specific toxicity
R. Nagle

Journal of pharmacological methods, 1987

To reduce structural complexity, rabbit kidneys were sliced perpendicular to their cortical-papillary axis to isolate four distinct cell groupings. This positional orientation allows identification of each renal cell type based on its location within the slice. A mechanical slicer was used to make several precision-cut slices rapidly from an oriented cylindrical core of renal tissue, with minimal tissue trauma. Slices were then submerged under a gently circulating oxygenated media in a fritted glass support system that maintains viability (intracellular K+/DNA ratio) and structural integrity (histology) for at least 30 h. A high dose of mercuric chloride (10(-3) M) was used to demonstrate the structural and biochemical changes of intoxicated slices. This method provides a controlled subchronic in vitro system for the study of the individual cell types involved in cell-specific renal toxicities and may also be a useful tool for addressing other pharmacological and physiological resea...

View PDFchevron_right
The Mechanism of Drug Nephrotoxicity and the Methods for Preventing Kidney Damage
Ewa Kwiatkowska

International Journal of Molecular Sciences

Acute kidney injury (AKI) is a global health challenge of vast proportions, as approx. 13.3% of people worldwide are affected annually. The pathophysiology of AKI is very complex, but its main causes are sepsis, ischemia, and nephrotoxicity. Nephrotoxicity is mainly associated with the use of drugs. Drug-induced AKI accounts for 19–26% of all hospitalized cases. Drug-induced nephrotoxicity develops according to one of the three mechanisms: (1) proximal tubular injury and acute tubular necrosis (ATN) (a dose-dependent mechanism), where the cause is related to apical contact with drugs or their metabolites, the transport of drugs and their metabolites from the apical surface, and the secretion of drugs from the basolateral surface into the tubular lumen; (2) tubular obstruction by crystals or casts containing drugs and their metabolites (a dose-dependent mechanism); (3) interstitial nephritis induced by drugs and their metabolites (a dose-independent mechanism). In this article, the m...

View PDFchevron_right
Development and validation of a new nephrotoxicity model mimicking cell physiology microenvironment
Natalia Sánchez

2017

The kidneys are very efficient organs that perform multiple functions in the body. One of the main functions performed by the kidneys is the elimination of waste products and excess fluid from the body through the urine. The regulation of body salts and acid content are functions played by these organs. In the kidney also takes place the production of different hormones. The kidney is made up of nephrons, which are the structural and functional units of these organs. The nephrons are composed by the following structures: The glomerulus, which is the first part of the nephron, where the plasma is filtered from the blood. Immediately afterward, we find the tubule, which structure is like a long narrow tube, where the filtered fluid from the blood is processed into the urine. The tubule is divided into different segments: proximal tubule, loop of Henle, distal tubule and collecting tube. In this Thesis, we focused on the study of the segment formed by the proximal tubule (PT). The main...

View PDFchevron_right
Evaluation of biomarkers for in vitro prediction of drug-induced nephrotoxicity: comparison of HK-2, immortalized human proximal tubule epithelial, and primary cultures of human proximal tubular cells
Mark Blaskovich, Lawrence Lash

Pharmacology Research & Perspectives, 2015

There has been intensive effort to identify in vivo biomarkers that can be used to monitor drug-induced kidney damage and identify injury before significant impairment occurs. Kidney injury molecule-1 (KIM-1), neutrophil gelatinaseassociated lipocalin (NGAL), and human macrophage colony stimulating factor (M-CSF) have been validated as urinary and plasma clinical biomarkers predictive of acute and chronic kidney injury and disease. Similar validation of a high throughput in vitro assay predictive of nephrotoxicity could potentially be implemented early in drug discovery lead optimization to reduce attrition at later stages of drug development. To assess these known in vivo biomarkers for their potential for in vitro screening of drug-induced nephrotoxicity, we selected a panel of nephrotoxic agents and examined their effects on the overexpression of nephrotoxicity biomarkers in immortalized (HK-2) and primary (commercially available and freshly in-house produced) human renal proximal tubule epithelial cells. Traditional cytotoxicity was contrasted with expression levels of KIM-1, NGAL, and M-CSF assessed using ELISA and real-time quantitative reverse transcription PCR. Traditional cytotoxicity assays and biomarker assays using HK-2 cells were both unsuitable for prediction of nephrotoxicity. However, increases in protein levels of KIM-1 and NGAL in primary cells were well correlated with dose levels of known nephrotoxic compounds, with limited correlation seen in M-CSF protein and mRNA levels. These results suggest that profiling compounds against primary cells with monitoring of biomarker protein levels may have potential as in vitro predictive assays of drug-induced nephrotoxicity.

View PDFchevron_right
Glomerular filtration drug injury: in vitro evaluation of functional and morphological podocyte perturbations
Olivier Delezay

Experimental cell research, 2017

The kidney is an organ that plays a major role in the excretion of numerous compounds such as drugs and chemicals. However, a great number of pharmacological molecules are nephrotoxic, affecting the efficiency of the treatment and increasing morbidity or mortality. Focusing on glomerular filtration, we propose in this study a simple and reproducible in vitro human model that is able to bring to light a functional podocyte injury, correlated with morphologic/phenotypic changes after drug exposure. This model was used for the evaluation of paracellular permeability of FITC-dextran molecules as well as FITC-BSA after different treatments. Puromycin aminonucleoside and adriamycin, compounds known to induce proteinuria in vivo and that serve here as positive nephrotoxic drug controls, were able to induce an important increase in fluorescent probe passage through the cell monolayer. Different molecules were then evaluated for their potential effect on podocyte filtration. Our results demo...

View PDFchevron_right

References (197)

  1. Alinejad S, Ghaemi K, Abdollahi M, Mehrpour O (2016) Nephrotoxic- ity of methadone: a systematic review. Springerplus 5(1):2087. https ://doi.org/10.1186/s4006 4-016-3757-1
  2. Anders MW (1980) Metabolism of drugs by the kidney. Kidney Int 18:636-647. https ://doi.org/10.1038/KI.1980.181
  3. Andreucci M, Faga T, Pisani A, Perticone M, Michael A (2017) The ischemic/nephrotoxic acute kidney injury and the use of renal biomarkers in clinical practice. Eur J Intern Med 39:1-8. https ://doi.org/10.1016/j.ejim.2016.12.001
  4. Arakawa H, Washio I, Matsuoka N et al (2017) Usefulness of kidney slices for functional analysis of apical reabsorptive transport- ers. Sci Rep 7:12814. https ://doi.org/10.1038/s4159 8-017- 12828 -z
  5. Aschauer L, Limonciel A, Wilmes A et al (2015) Application of RPTEC/TERT1 cells for investigation of repeat dose nephro- toxicity: a transcriptomic study. Toxicol In Vitro 30:106-116. https ://doi.org/10.1016/J.TIV.2014.10.005
  6. Astashkina A, Mann B, Grainger DW (2012) A critical evaluation of in vitro cell culture models for high-throughput drug screen- ing and toxicity. Pharmacol Ther 134(1):82-106. https ://doi. org/10.1016/j.pharm thera .2012.01.001
  7. Azab AN, Shnaider A, Osher Y, Wang D, Bersudsky Y, Belmaker RH (2015) Lithium nephrotoxicity. Int J. Bipolar Disord 3(1):28. https ://doi.org/10.1186/s4034 5-015-0028-y
  8. Bajaj P, Chowdhury SK, Yucha R, Kelly EJ, Xiao G (2018) Emerg- ing kidney models to investigate metabolism, transport, and toxicity of drugs and xenobiotics (1521-009X (Electronic))
  9. Barnett LMA, Cummings BS (2018) Nephrotoxicity and renal patho- physiology: a contemporary perspective. Toxicol Sci 164:379- 390. https ://doi.org/10.1093/toxsc i/kfy15 9
  10. Barré-Sinoussi F, Montagutelli X (2015) Animal models are essen- tial to biological research: issues and perspectives. Future Sci OA 1(4):FSO63. https ://doi.org/10.4155/fso.15.63
  11. Basile DP, Anderson MD, Sutton TA (2012) Pathophysiology of acute kidney injury. Compr Physiol 2:1303-1353. https ://doi. org/10.1002/cphy.c1100 41
  12. Basu RK, Wheeler DS (2013) Kidney-lung cross-talk and acute kid- ney injury. Pediatr Nephrol (Berlin, Germany) 28:2239-2248. https ://doi.org/10.1007/s0046 7-012-2386-3
  13. Bello-Reuss E, Reuss L (1983) Homeostatic and excretory functions of the kidney the kidney and body fluids in health and disease. Springer, Boston, pp 35-63
  14. Bird ST, Etminan M, Brophy JM, Hartzema AG, Delaney JA (2013) Risk of acute kidney injury associated with the use of fluoro- quinolones. CMAJ Can Med Assoc J journal de l'Association medicale canadienne 185(10):E475-E482. https ://doi. org/10.1503/cmaj.12173 0
  15. Bolignano D, Donato V, Coppolino G et al (2008) Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kid- ney damage. Am J Kidney Dis 52(3):595-605. https ://doi. org/10.1053/j.ajkd.2008.01.020
  16. Bolisetty S, Agarwal A (2011) Urine albumin as a biomarker in acute kidney injury. Am J Physiol Renal Physiol 300(3):F626-F627. https ://doi.org/10.1152/ajpre nal.00004 .2011
  17. Breda PC, Wiech T, Meyer-Schwesinger C et al (2019) Renal proxi- mal tubular epithelial cells exert immunomodulatory function by driving inflammatory CD4+ T cell responses. Am J Physiol Renal Physiol 317(1):F77-F89. https ://doi.org/10.1152/ajpre nal.00427 .2018
  18. Brodsky SV (2014) Anticoagulants and acute kidney injury: clini- cal and pathology considerations. Kidney Res Clin Pract 33(4):174-180. https ://doi.org/10.1016/j.krcp.2014.11.001
  19. Brown CD, Sayer R, Windass AS et al (2008a) Characterisation of human tubular cell monolayers as a model of proximal tubular xenobiotic handling. Toxicol Appl Pharmacol 233(3):428-438
  20. Brown CDA, Sayer R, Windass AS et al (2008b) Characterisation of human tubular cell monolayers as a model of proximal tubular xenobiotic handling. Toxicol Appl Pharmacol 233:428-438. https ://doi.org/10.1016/J.TAAP.2008.09.018
  21. Bülow RD, Boor P (2019) Extracellular matrix in kidney fibrosis: more than just a scaffold. J Histochem Cytochem. https ://doi. org/10.1369/00221 55419 84938 8
  22. Busauschina A, Schnuelle P, van der Woude FJ (2004) Cyclosporine nephrotoxicity. Transpl Proc 36(2 Suppl):229s-233s. https ://doi. org/10.1016/j.trans proce ed.2004.01.021
  23. Cai Z, Xin J, Pollock DM, Pollock JS (2000) Shear stress-mediated NO production in inner medullary collecting duct cells. Am J Physiol Renal Physiol 279(2):F270-F274. https ://doi.org/10.1152/ajpre nal.2000.279.2.F270
  24. Chang SY, Weber EJ, Ness KV, Eaton DL, Kelly EJ (2016) Liver and kidney on chips: microphysiological models to understand trans- porter function. Clin Pharmacol Ther 100(5):464-478. https :// doi.org/10.1002/cpt.436
  25. Chang S-Y, Weber EJ, Sidorenko VS et al (2017) Human liver-kidney model elucidates the mechanisms of aristolochic acid nephro- toxicity. JCI Insight 2(22):e95978. https ://doi.org/10.1172/jci. insig ht.95978
  26. Chapman AB, Devuyst O, Eckardt K-U et al (2015) Autosomal-dom- inant polycystic kidney disease (ADPKD): executive summary from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int 88(1):17-27. https ://doi. org/10.1038/ki.2015.59
  27. Chevtchik NV, Mihajlovic M, Fedecostante M et al (2018) A bioarti- ficial kidney device with polarized secretion of immune modu- lators. J Tissue Eng Regen Med 12:1670-1678. https ://doi. org/10.1002/term.2694
  28. Choudhury D, Ahmed Z (2006) Drug-associated renal dysfunction and injury. Nat Clin Pract Nephrol 2(2):80-91. https ://doi. org/10.1038/ncpne ph007 6
  29. Coco TJ, Klasner AE (2004) Drug-induced rhabdomyolysis. Curr Opin Pediatr 16(2):206-210
  30. Cook D, Brown D, Alexander R et al (2014) Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional frame- work. Nat Rev Drug Discovery 13:419. https ://doi.org/10.1038/ nrd43 09
  31. Czerniecki SM, Cruz NM, Harder JL et al (2018) High-throughput screening enhances kidney organoid differentiation from human pluripotent stem cells and enables automated multidimensional phenotyping. Cell Stem Cell 22(6):929.e4-940.e4. https ://doi. org/10.1016/j.stem.2018.04.022
  32. de Chuva de Sousa Lopes SM (2019) Accelerating maturation of kidney organoids. Nat Mater 18(4):303-304. https ://doi. org/10.1038/s4156 3-019-0326-3
  33. De Kanter R, Olinga P, De Jager MH, Merema MT, Meijer DK, Groothius GM (1999) Organ slices as an in vitro test system for drug metabolism in human liver, lung and kidney. Toxicol In Vitro 13(4-5):737-744
  34. Deray G (2002) Amphotericin B nephrotoxicity. The Journal of antimicrobial chemotherapy 49(Suppl 1):37-41. https ://doi. org/10.1093/jac/49.suppl _1.37
  35. Desrochers T, Suter-Dick L, Roth A, Kaplan D (2013) Bioengineered 3D human kidney tissue, a platform for the determination of nephrotoxicity. PLoS One 8:e59219. https ://doi.org/10.1371/ annot ation /fb32f 1b8-7397-40be-bbf9-b80e6 77630 43
  36. DesRochers TM, Kimmerling EP, Jandhyala DM et al (2015) Effects of Shiga toxin type 2 on a bioengineered three-dimensional model of human renal tissue. Infect Immun 83(1):28-38. https ://doi. org/10.1128/IAI.02143 -14
  37. Dieterle F, Perentes E, Cordier A et al (2010a) Urinary clusterin, cysta- tin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat Biotechnol 28(5):463-469. https ://doi.org/10.1038/nbt.1622
  38. Dieterle F, Sistare F, Goodsaid F et al (2010b) Renal biomarker qualifi- cation submission: a dialog between the FDA-EMEA and Predic- tive Safety Testing Consortium. Nat Biotechnol 28(5):455-462. https ://doi.org/10.1038/nbt.1625
  39. Dixit M, Doan T, Kirschner R, Dixit N (2010) significant acute kidney injury due to non-steroidal anti-inflammatory drugs: inpatient setting. Pharmaceuticals (Basel, Switzerland) 3:1279-1285. https ://doi.org/10.3390/ph304 1279
  40. du Cheyron D, Daubin C, Poggioli J et al (2003) Urinary measurement of Na+/H+ exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF. Am J Kidney Dis 42(3):497-506
  41. Eddy AA, Fogo AB (2006) Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action. J Am Soc Nephrol 17(11):2999-3012. https ://doi.org/10.1681/ asn.20060 50503
  42. Eirin A, Lerman A, Lerman LO (2017) The emerging role of mito- chondrial targeting in kidney disease. Handb Exp Pharmacol 240:229-250. https ://doi.org/10.1007/164_2016_6
  43. Ejaz P, Bhojani K, Joshi VR (2004) NSAIDs and kidney. J Assoc Phy- sicians India 52:632-640
  44. Eshbach ML, Weisz OA (2017) Receptor-mediated endocytosis in the proximal tubule. Annu Rev Physiol 79(1):425-448. https ://doi. org/10.1146/annur ev-physi ol-02251 6-03423 4
  45. Fedecostante M, Onciu OG, Westphal KGC, Masereeuw R (2017) Towards a bioengineered kidney: recellularization strategies for decellularized native kidney scaffolds. Int J Artif Org 40:150- 158. https ://doi.org/10.5301/ijao.50005 64
  46. Fedecostante M, Westphal KGC, Buono MF et al (2018) recellularized native kidney scaffolds as a novel tool in nephrotoxicity screen- ing. Drug Metab Dispos Biol Fate Chem 46(9):1338-1350. https ://doi.org/10.1124/dmd.118.08072 1
  47. Feher J (2017) Tubular Reabsorption and Secretion. Quant Hum Phys- iol. https ://doi.org/10.1016/b978-0-12-80088 3-6.00072 -0
  48. Fernandez-Fernandez B, Montoya-Ferrer A, Sanz AB et al (2011) Tenofovir nephrotoxicity: 2011 update. AIDS Res Treat 2011:354908. https ://doi.org/10.1155/2011/35490 8
  49. Frazier KS, Obert LA (2018) Drug-induced glomerulonephritis: the spectre of biotherapeutic and antisense oligonucleotide immune activation in the kidney. Toxicol Pathol 46(8):904-917. https :// doi.org/10.1177/01926 23318 78939 9
  50. Freedman BS, Brooks CR, Lam AQ et al (2015) Modelling kidney dis- ease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Nat Commun 6:8715. https ://doi. org/10.1038/ncomm s9715
  51. Frochot V, Bazin D, Letavernier E, Jouanneau C, Haymann J-P, Daudon M (2016) Nephrotoxicity induced by drugs: the case of foscar- net and atazanavir-a SEM and μFTIR investigation. C R Chim 19(11):1565-1572. https ://doi.org/10.1016/j.crci.2016.08.007
  52. Georgiev T, Iliev R, Mihailova S et al (2011) The isolated perfused kidney models-certain aspects. Trakia J Sci 9(3):82-87
  53. Ghane Shahrbaf F, Assadi F (2015) Drug-induced renal disorders. J Renal Inj Prev 4(3):57-60. https ://doi.org/10.12861 /jrip.2015.12
  54. Giacomini KM, Huang SM, Tweedie DJ et al (2010) Membrane trans- porters in drug development. Nat Rev Drug Discov 9(3):215-236
  55. Guengerich FP (2011) Mechanisms of drug toxicity and relevance to pharmaceutical development. Drug Metab Pharmacokinet 26(1):3-14
  56. Han WK, Waikar SS, Johnson A et al (2008) Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int 73(7):863-869. https ://doi.org/10.1038/sj.ki.50027 15
  57. Han C, Lee Y-K, Park HC et al (2019) Serum alkaline phosphatase and γ-glutamyl transferase in acute pyelonephritis. Kidney Res Clin Pract 38(2):205-211. https ://doi.org/10.23876 /j.krcp.18.0074
  58. Hanemann AL, Liborio AB, Daher EF et al (2013) Monocyte chemot- actic protein-1 (MCP-1) in patients with chronic schistosomiasis mansoni: evidences of subclinical renal inflammation. PLoS One 8(11):e80421. https ://doi.org/10.1371/journ al.pone.00804 21
  59. Hara M, Suganuma A, Yanagisawa N, Imamura A, Hishima T, Ando M (2015) Atazanavir nephrotoxicity. Clin Kidney J 8(2):137-142. https ://doi.org/10.1093/ckj/sfv01 5
  60. Haussler MR, Whitfield GK, Haussler CA et al (2016) 1,25-Dihy- droxyvitamin D and klotho: a tale of two renal hormones com- ing of age. Vitam Horm 100:165-230. https ://doi.org/10.1016/ BS.VH.2015.11.005
  61. Hayashi H, Sato W, Kosugi T et al (2017) Efficacy of urinary mid- kine as a biomarker in patients with acute kidney injury. Clin Exp Nephrol 21(4):597-607. https ://doi.org/10.1007/s1015 7-016-1318-0
  62. Hidaka S, Kranzlin B, Gretz N, Witzgall R (2002) Urinary clusterin levels in the rat correlate with the severity of tubular damage and may help to differentiate between glomerular and tubular inju- ries. Cell Tissue Res 310(3):289-296. https ://doi.org/10.1007/ s0044 1-002-0629-5
  63. Hitti WA, Anderson J (2005) Cholesterol emboli-induced renal fail- ure and gastric ulcer after thrombolytic therapy. South Med J 98(2):235-237. https ://doi.org/10.1097/01.Smj.00001 52754 .12363 .45
  64. Holechek MJ (2003) Glomerular filtration: an overview. Nephrol Nurs J J Am Nephrol Nurs Assoc 30:285-290 (quiz 291-2)
  65. Homan KA, Kolesky DB, Skylar-Scott MA et al (2016) Bioprinting of 3D convoluted renal proximal tubules on perfusable chips. Sci Rep. https ://doi.org/10.1038/srep3 4845
  66. Homan KA, Gupta N, Kroll KT et al (2019) Flow-enhanced vasculari- zation and maturation of kidney organoids in vitro. Nat Methods 16(3):255-262. https ://doi.org/10.1038/s4159 2-019-0325-y
  67. Htike NL, Santoro J, Gilbert B, Elfenbein IB, Teehan G (2012) Biopsy- proven vancomycin-associated interstitial nephritis and acute tubular necrosis. Clin Exp Nephrol 16(2):320-324. https ://doi. org/10.1007/s1015 7-011-0559-1
  68. Izzedine H, Launay-Vacher V, Deray G (2005) Antiviral drug-induced nephrotoxicity. Am J Kidney Dis 45(5):804-817
  69. Jafari A, Khalili H, Dashti-Khavidaki S (2014) Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, progno- sis and proposed agents for prevention. Eur J Clin Pharmacol 70(9):1029-1040. https ://doi.org/10.1007/s0022 8-014-1712-z
  70. Jang KJ, Mehr AP, Hamilton GA et al (2013) Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assess- ment. Integr Biol (United Kingdom). https ://doi.org/10.1039/ c3ib4 0049b
  71. Jansen J, Schophuizen CMS, Wilmer MJ et al (2014) A morpho- logical and functional comparison of proximal tubule cell lines established from human urine and kidney tissue. Exp Cell Res 323(1):87-99. https ://doi.org/10.1016/j.yexcr .2014.02.011
  72. Jansen J, De Napoli IE, Fedecostante M et al (2015) Human proximal tubule epithelial cells cultured on hollow fibers: living mem- branes that actively transport organic cations. Sci Rep 5:16702. https ://doi.org/10.1038/srep1 6702
  73. Jansen J, Fedecostante M, Wilmer MJ et al (2016a) Bioengineered kidney tubules efficiently excrete uremic toxins. Sci Rep 6:1-12. https ://doi.org/10.1038/srep2 6715
  74. Jansen J, Fedecostante M, Wilmer MJ et al (2016b) Bioengineered kidney tubules efficiently excrete uremic toxins. Sci Rep 6:26715. https ://doi.org/10.1038/srep2 6715
  75. Jansen J, Jansen K, Neven E et al (2019) Remote sensing and signaling in kidney proximal tubules stimulates gut microbiome-derived organic anion secretion. Proc Natl Acad Sci USA. https ://doi. org/10.1073/pnas.18218 09116
  76. Jenkinson SE, Chung GW, van Loon E, Bakar NS, Dalzell AM, Brown CD (2012a) The limitations of renal epithelial cell line HK-2 as a model of drug transporter expression and function in the proximal tubule. Pflugers Arch 464(6):601-611
  77. Jenkinson SE, Chung GW, van Loon E, Bakar NS, Dalzell AM, Brown CDA (2012b) The limitations of renal epithelial cell line HK-2 as a model of drug transporter expression and function in the proximal tubule. Pflügers Arch Eur J Physiol 464:601-611. https ://doi.org/10.1007/s0042 4-012-1163-2
  78. Jia HM, Huang LF, Zheng Y, Li WX (2017) Diagnostic value of uri- nary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor binding protein 7 for acute kidney injury: a meta- analysis. Crit Care (London, England) 21(1):77. https ://doi. org/10.1186/s1305 4-017-1660-y
  79. Kakoki M, Smithies O (2009) The kallikrein-kinin system in health and in diseases of the kidney. Kidney Int 75:1019. https ://doi. org/10.1038/KI.2008.647
  80. Kalyesubula R, Perazella MA (2011) Nephrotoxicity of HAART. AIDS Res Treat 2011:562790. https ://doi.org/10.1155/2011/56279 0
  81. Kamijo A, Sugaya T, Hikawa A et al (2006) Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease. Mol Cell Biochem 284(1-2):175-182. https ://doi. org/10.1007/s1101 0-005-9047-9
  82. Kaminski Michael M, Tosic J, Kresbach C et al (2016) Direct repro- gramming of fibroblasts into renal tubular epithelial cells by defined transcription factors. Nat Cell Biol 18:1269. https ://doi. org/10.1038/ncb34 37
  83. Kandasamy K, Chuah JKC, Su R et al (2015) Prediction of drug- induced nephrotoxicity and injury mechanisms with human induced pluripotent stem cell-derived cells and machine learn- ing methods. Sci Rep 5:12337. https ://doi.org/10.1038/srep1 2337
  84. Kazancioğlu R (2013) Risk factors for chronic kidney disease: an update. Kidney Int Suppl 3:368. https ://doi.org/10.1038/KISUP .2013.79
  85. Kim J-H, Hwang K-H, Park K-S, Kong ID, Cha S-K (2015) Biological role of anti-aging protein Klotho. J Lifestyle Med 5:1-6. https :// doi.org/10.15280 /jlm.2015.5.1.1
  86. Kipp R, Kellerman PS (2009) Chronic kidney disease. Pathophysiol Kidney Dis Hypertens. https ://doi.org/10.1016/b978-1-4160- 4391-1.50018 -7
  87. Kobayashi A, Valerius MT, Mugford JW et al (2008) Six2 defines and regulates a multipotent self-renewing nephron progenitor popu- lation throughout mammalian kidney development. Cell Stem Cell 3(2):169-181. https ://doi.org/10.1016/j.stem.2008.05.020
  88. Koeppen BM, Stanton BA (2013) Renal physiology, 5th edn. Elsevier. ISBN: 978-0-323-08691-2
  89. Kowalkowski K, Klapczynski M, Blomme E, Buck W, Liguori M (2017) Evaluating in vitro canine kidney slices as a renal toxicity model using nephrotoxic agents cisplatin and cadmium chloride. FASEB J 31:819.8. https ://doi.org/10.1096/faseb j.31.1_suppl ement .819.8
  90. Kumar R, Tebben PJ, Thompson JR (2012) Vitamin D and the kidney. Arch Biochem Biophys 523:77-86. https ://doi.org/10.1016/j. abb.2012.03.003
  91. Kumar SV, Er PX, Lawlor KT et al (2019) Kidney micro-organoids in suspension culture as a scalable source of human pluripotent stem cell-derived kidney cells. Development 146(5):dev172361. https ://doi.org/10.1242/dev.17236 1
  92. Lam AQ, Freedman BS, Morizane R, Lerou PH, Valerius MT, Bonven- tre JV (2014) Rapid and efficient differentiation of human pluri- potent stem cells into intermediate mesoderm that forms tubules expressing kidney proximal tubular markers. J Am Soc Nephrol JASN 25:1211-1225. https ://doi.org/10.1681/ASN.20130 80831
  93. Lameire N (2014) Nephrotoxicity of recent anti-cancer agents. Clin Kidney J 7(1):11-22. https ://doi.org/10.1093/ckj/sft13 5
  94. Lameire N, Van Biesen W, Vanholder R (2005) Acute renal failure. Lancet (London, England) 365(9457):417-430. https ://doi. org/10.1016/s0140 -6736(05)17831 -3
  95. Lane K, Dixon JJ, Macphee IAM, Philips BJ (2013) Renohepatic cross- talk: does acute kidney injury cause liver dysfunction? Nephrol Dial Transplant 28:1634-1647. https ://doi.org/10.1093/ndt/gft09 1
  96. Lee J, Kim S (2018) Kidney-on-a-chip: a new technology for predicting drug efficacy, interactions, and drug-induced nephrotoxicity. Curr Drug Metab 19:577-583. https ://doi.org/10.2174/13892 00219 66618 03091 01844
  97. Lee EJ, Song SA, Mun HW, Yoo KH et al (2014) Blockade of interleu- kin-8 receptor signalling inhibits cyst development in vitro, via suppression of cell proliferation in autosomal polycystic kidney disease (1440-1797 (Electronic))
  98. Levy JB, Pusey CD (2000) Nephrotoxicity of intravenous immuno- globulin. QJM Mon J Assoc Physicians 93(11):751-755. https ://doi.org/10.1093/qjmed /93.11.751
  99. Liang Y, Li S, Chen L (2015a) The physiological role of drug trans- porters. Protein Cell 6:334. https ://doi.org/10.1007/S1323 8-015-0148-2
  100. Liang Y, Zhang J, Zhou Y, Xing G, Zhao G, Liu Z (2015b) Prolif- eration and cytokine production of human mesangial cells stimulated by secretory IgA isolated from patients with IgA nephropathy. Cell Physiol Biochem 36(5):1793-1808. https :// doi.org/10.1159/00043 0151
  101. Liu Y, Yin Y, Liu XZ et al (2015) Retrospective analysis of vanco- mycin nephrotoxicity in elderly Chinese patients. Pharmacology 95(5-6):279-284. https ://doi.org/10.1159/00038 1783
  102. Liu X, Guan Y, Xu S et al (2016) Early predictors of acute kidney injury: a narrative review. Kidney Blood Press Res 41(5):680- 700. https ://doi.org/10.1159/00044 7937
  103. Liu Y, Liu B, Liu Y et al (2019) MicroRNA expression profile by next-generation sequencing in a novel rat model of contrast- induced acute kidney injury. Ann Transl Med 7(8):178. https :// doi.org/10.21037 /atm.2019.04.44
  104. Lopez MLSS, Gomez RA (2010) The renin phenotype: roles and regu- lation in the kidney. Curr Opin Nephrol Hypertens 19:366-371. https ://doi.org/10.1097/MNH.0b013 e3283 3aff3 2
  105. Lopez-Novoa JM, Quiros Y, Vicente L, Morales AI, Lopez-Hernandez FJ (2011) New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int 79(1):33- 45. https ://doi.org/10.1038/ki.2010.337
  106. Lote CJ (2012) Essential anatomy of the kidney principles of renal physiology. Springer, New York, pp 21-32
  107. Lucas GNC, Leitão ACC, Alencar RL, Xavier RMF, Daher EDF, Silva Junior GBD (2019) Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs. J Braz J Neph- rol 41:124-130
  108. Macedo E, Mehta RL (2009) Prerenal Failure: from Old Concepts to New Paradigms. Current opinion in critical care 15:467. https :// doi.org/10.1097/MCC.0B013 E3283 32F6E 3
  109. Mae S-I, Shono A, Shiota F et al (2013) Monitoring and robust induc- tion of nephrogenic intermediate mesoderm from human pluri- potent stem cells. Nat Commun 4:1367. https ://doi.org/10.1038/ ncomm s2378
  110. Makris K, Spanou L (2016) Acute kidney injury: definition, patho- physiology and clinical phenotypes. Clin Biochem Rev 37:85
  111. Małyszko J, Kozłowska K, Kozłowski L, Małyszko J (2016) Nephro- toxicity of anticancer treatment. Nephrol Dial Transplant 32(6):924-936. https ://doi.org/10.1093/ndt/gfw33 8
  112. Manabe K, Kamihata H, Motohiro M, Senoo T, Yoshida S, Iwasaka T (2012) Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury. Eur J Clin Investig 42(5):557-563. https ://doi.org/10.111 1/j.1365-2362.2011.02620 .x
  113. Markowitz GS, Perazella MA (2005) Drug-induced renal fail- ure: a focus on tubulointerstitial disease. Clin Chim Acta Int J Clin Chem 351(1-2):31-47. https ://doi.org/10.1016/j. cccn.2004.09.005
  114. Markowitz GS, Fine PL, Stack JI et al (2003) Toxic acute tubular necro- sis following treatment with zoledronate (Zometa). Kidney Int 64(1):281-289. https ://doi.org/10.1046/j.1523-1755.2003.00071 .x
  115. Marti H-P, Frey FJ (2005) Nephrotoxicity of rapamycin: an emerging problem in clinical medicine. Nephrol Dial Transplant 20(1):13- 15. https ://doi.org/10.1093/ndt/gfh63 9
  116. McCann B, Hunter R, McCann J (2002) Cocaine/heroin induced rhabdomyolysis and ventricular fibrillation. Emerg Med J 19(3):264. https ://doi.org/10.1136/emj.19.3.264
  117. Medina PJ, Sipols JM, George JN (2001) Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol 8(5):286-293
  118. Mihajlovic M, Fedecostante M, Oost MJ et al (2017) Role of vitamin D in maintaining renal epithelial barrier function in uremic conditions. Int J Mol Sci 18(12):2531. https ://doi.org/10.3390/ ijms1 81225 31
  119. Mihajlovic M, Hariri S, Westphal KCG et al (2019) Safety evalua- tion of conditionally immortalized cells for renal replacement therapy. Oncotarget 10(51):5332-5348. https ://doi.org/10.18632 /oncot arget .27152
  120. Miller RP, Tadagavadi RK, Ramesh G, Reeves WB (2010) Mecha- nisms of Cisplatin nephrotoxicity. Toxins (Basel) 2(11):2490- 2518. https ://doi.org/10.3390/toxin s2112 490
  121. Morizane R, Lam AQ, Freedman BS, Kishi S, Valerius MT, Bonven- tre JV (2015) Nephron organoids derived from human pluri- potent stem cells model kidney development and injury. Nat Biotechnol 33:1193. https ://doi.org/10.1038/nbt.3392
  122. Murphy RA, Stafford RM, Petrasovits BA, Boone MA, Valentovic MA (2017) Establishment of HK-2 cells as a relevant model to study tenofovir-induced cytotoxicity. Int J Mol Sci. https :// doi.org/10.3390/ijms1 80305 31
  123. Naughton CA (2008a) Drug-induced nephrotoxicity. Am Fam Physi- cian 78(6):743-750
  124. Naughton CA (2008b) Drug-induced nephrotoxicity. Am Fam Physi- cian 78:743-750
  125. Navis G, Faber HJ, de Zeeuw D, de Jong PE (1996) ACE inhibi- tors and the kidney. Drug Saf 15:200-211. https ://doi. org/10.2165/00002 018-19961 5030-00005
  126. Nieskens TTG, Peters JGP, Schreurs MJ et al (2016) A human renal proximal tubule cell line with stable organic anion trans- porter 1 and 3 expression predictive for antiviral-induced toxicity. AAPS J 18:465-475. https ://doi.org/10.1208/s1224 8-016-9871-8
  127. Nigam SK (2018) The SLC22 transporter family: a paradigm for the impact of drug transporters on metabolic pathways, signal- ing, and disease. Annu Rev Pharmacol Toxicol 58(1):663-687. https ://doi.org/10.1146/annur ev-pharm tox-01061 7-05271 3
  128. Nigam SK, Wu W, Bush KT, Hoenig MP, Blantz RC, Bhatnagar V (2015) Handling of drugs, metabolites, and uremic toxins by kidney proximal tubule drug transporters. Clin J Am Soc Neph- rol 10(11):2039-2049. https ://doi.org/10.2215/cjn.02440 314
  129. Nissim I, Horyn O, Daikhin Y et al (2006) Ifosfamide-induced nephrotoxicity: mechanism and prevention. Can Res 66(15):7824-7831. https ://doi.org/10.1158/0008-5472. Can-06-1043
  130. Ohana YH, Liron T, Prutchi-Sagiv S, Mittelman M, Souroujon MC, Neumann D (2013) Erythropoietin. In: Handbook of biologically active peptides, pp 1619-1626. https ://doi.org/10.1016/b978-0- 12-38509 5-9.00221 -9
  131. Olyaei AJ, de Mattos AM, Bennett WM (2001) Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr Opin Crit Care 7(6):384-389
  132. Onopiuk A, Tokarzewicz A, Gorodkiewicz E (2015) Cystatin C: a kid- ney function biomarker. Adv Clin Chem 68:57-69. https ://doi. org/10.1016/bs.acc.2014.11.007
  133. Ozer JS, Dieterle F, Troth S et al (2010) A panel of urinary biomark- ers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function. Nat Biotechnol 28(5):486-494. https ://doi.org/10.1038/nbt.1627
  134. Pahl MV, Vaziri ND, Yuan J, Adler SG (2010) Upregulation of mono- cyte/macrophage HGFIN (Gpnmb/Osteoactivin) expression in end-stage renal disease. Clin J Am Soc Nephrol CJASN 5(1):56- 61. https ://doi.org/10.2215/cjn.03390 509
  135. Palmer BF (2002) Renal dysfunction complicating the treatment of hypertension. N Engl J Med 347(16):1256-1261. https ://doi. org/10.1056/NEJMr a0206 76
  136. Patzer L (2008) Nephrotoxicity as a cause of acute kidney injury in children. Pediatr Nephrol 23(12):2159-2173. https ://doi. org/10.1007/s0046 7-007-0721-x
  137. Pazhayattil GS, Shirali AC (2014) Drug-induced impairment of renal function. Int J Nephrol Renovasc Dis 7:457-468. https ://doi. org/10.2147/IJNRD .S3974 7
  138. Perazella MA (2005) Drug-induced nephropathy: an update. Expert Opin Drug Saf 4(4):689-706. https ://doi.org/10.1517/14740 338.4.4.689
  139. Petros WP, Hopkins PJ, Spruill S et al (2005) Associations between drug metabolism genotype, chemotherapy pharmacokinetics, and overall survival in patients with breast cancer. J Clin Oncol Off J Am Soc Clin Oncol 23(25):6117-6125. https ://doi.org/10.1200/ jco.2005.06.075
  140. Pianta TJ, Peake PW, Pickering JW, Kelleher M, Buckley NA, Endre ZH (2015) Clusterin in kidney transplantation: novel biomarkers versus serum creatinine for early prediction of delayed graft func- tion. Transplantation 99(1):171-179. https ://doi.org/10.1097/ tp.00000 00000 00025 6
  141. Piazzon N, Bernet F, Guihard L et al (2015) Urine Fetuin-A is a bio- marker of autosomal dominant polycystic kidney disease pro- gression. J Transl Med 13:103. https ://doi.org/10.1186/s1296 7-015-0463-7
  142. Price SA, Davies D, Rowlinson R et al (2010) Characterization of renal papillary antigen 1 (RPA-1), a biomarker of renal pap- illary necrosis. Toxicol Pathol 38(3):346-358. https ://doi. org/10.1177/01926 23310 36224 6
  143. Raghavan V, Weisz OA (2016) Discerning the role of mechanosensors in regulating proximal tubule function. Am J Physiol Renal Phys- iol 310(1):F1-F5. https ://doi.org/10.1152/ajpre nal.00373 .2015
  144. Reeves WB, Kwon O, Ramesh G (2008) Netrin-1 and kidney injury. I. Netrin-1 is an early biomarker of acute kidney injury. Am J Phys- iol Renal Physiol 294(4):F731-F738. https ://doi.org/10.1152/ ajpre nal.00507 .2007
  145. Rodriguez-Barbero A, L'Azou B, Cambar J, Löpezlöpez-Novoa JM (2000) Potential use of isolated glomeruli and cultured mesan- gial cells as in vitro models to assess nephrotoxicity. Cell Biol Toxicol 16:145-153
  146. Ronco C, Cicoira M, McCullough PA (2012) Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J Am Coll Cardiol 60:1031-1042. https ://doi. org/10.1016/J.JACC.2012.01.077
  147. Rossert J (2001) Drug-induced acute interstitial nephritis. Kidney Int 60(2):804-817. https ://doi.org/10.1046/j.1523-1755.2001.06000 2804.x
  148. Rostami-Hodjegan A (2012) Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology. Clin Pharmacol Ther 92(1):50-61. https ://doi.org/10.1038/clpt.2012.65
  149. Ryan MJ, Johnson G, Kiiu J, Fuerstenberg SM, Zager RA, Torok-Storb B (1994) HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 45:48-57
  150. Sakairi T, Abe Y, Kajiyama H et al (2010) Conditionally immortal- ized human podocyte cell lines established from urine. Am J Physiol Renal Physiol 298:F557. https ://doi.org/10.1152/AJPRE NAL.00509 .2009
  151. Sakolish C, Weber EJ, Kelly EJ et al (2018) technology transfer of the microphysiological systems: a case study of the human proximal tubule tissue chip. Sci Rep 8(1):14882. https ://doi.org/10.1038/ s4159 8-018-33099 -2
  152. Sampathkumar K, Rajiv A, Sampathkumar D (2016) Analgesic nephropathy-a painful progression. Clin Med Insights Urol. https ://doi.org/10.4137/cmu.s1317 9
  153. Sawai K, Mukoyama M, Mori K et al (2007) Expression of CCN1 (CYR61) in developing, normal, and diseased human kidney. Am J Physiol Renal Physiol 293(4):F1363-F1372. https ://doi. org/10.1152/ajpre nal.00205 .2007
  154. Schafer JA, Watkins ML, Li L, Herter P, Haxelmans S, Schlatter E (1997) A simplified method for isolation of large num- bers of defined nephron segments. Am J Physiol Renal Physiol 273(4):F650-F657. https ://doi.org/10.1152/ajpre nal.1997.273.4.f650
  155. Schmouder RL, Strieter RM, Wiggins RC, Chensue SW, Kunkel SL (1992) In vitro and in vivo interleukin-8 production in human renal cortical epithelia. Kidney Int 41:98
  156. Schutgens F, Rookmaaker MB, Margaritis T et al (2019) Tubuloids derived from human adult kidney and urine for personalized disease modeling. Nat Biotechnol 37:303-313. https ://doi. org/10.1038/s4158 7-019-0048-8
  157. Secker PF, Luks L, Schlichenmaier N, Dietrich DR (2017) RPTEC/ TERT1 cells form highly differentiated tubules when cultured in a 3D matrix (1868-596X (Print))
  158. Secker PF, Schlichenmaier N, Beilmann M, Deschl U, Dietrich DR (2019) Functional transepithelial transport measurements to detect nephrotoxicity in vitro using the RPTEC/TERT1 cell line. Arch Toxicol. https ://doi.org/10.1007/s0020 4-019-02469 -8
  159. Shimamoto K, Iimura O (1989) Physiological role of renal kallikrein- kinin system in human. Adv Exp Med Biol 247A:87-96
  160. Simon-Friedt BR, Wilson MJ, Blake DA, Yu H, Eriksson Y, Wick- liffe JK (2015) The RPTEC/TERT1 cell line as an improved tool for in vitro nephrotoxicity assessments. Biol Trace Elem Res 166:66-71. https ://doi.org/10.1007/s1201 1-015-0339-y
  161. Sjögren A-K, Breitholtz K, Ahlberg E et al (2018) A novel multi-para- metric high content screening assay in ciPTEC-OAT1 to predict drug-induced nephrotoxicity during drug discovery. Arch Toxicol 92:3175-3190. https ://doi.org/10.1007/s0020 4-018-2284-y
  162. Stray KM, Bam RA, Birkus G et al (2013) Evaluation of the effect of cobicistat on the in vitro renal transport and cytotoxicity potential of tenofovir. Antimicrob Agents Chemother 57(10):4982. https ://doi.org/10.1128/AAC.00712 -13
  163. Takasato M, Er PX, Becroft M et al (2014) Directing human embry- onic stem cell differentiation towards a renal lineage generates a self-organizing kidney. Nat Cell Biol 16:118-126. https ://doi. org/10.1038/ncb28 94
  164. Takasato M, Er PX, Chiu HS et al (2015) Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature 526:564-568. https ://doi.org/10.1038/ natur e1569 5
  165. Troth SP, Simutis F, Friedman GS, Todd S, Sistare FD (2019) Kidney SAFETY ASSESSMENT: CURRENT PRACTICES IN DRUG DEVELOPMENT. Semin Nephrol 39(2):120-131. https ://doi. org/10.1016/j.semne phrol .2018.12.002
  166. Uehara T, Yamate J, Torii M, Maruyama T (2011) Comparative nephrotoxicity of Cisplatin and nedaplatin: mechanisms and histopathological characteristics. J Toxicol Pathol 24(2):87-94. https ://doi.org/10.1293/tox.24.87
  167. Uetake R, Sakurai T, Kamiyoshi A et al (2014) Adrenomedullin- RAMP2 system suppresses ER stress-induced tubule cell death and is involved in kidney protection. PLoS One 9(2):e87667. https ://doi.org/10.1371/journ al.pone.00876 67
  168. Vaidya VS, Ferguson MA, Bonventre JV (2008a) Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol 48:463-493. https :// doi.org/10.1146/annur ev.pharm tox.48.11300 6.09461 5
  169. Vaidya VS, Waikar SS, Ferguson MA et al (2008b) Urinary biomark- ers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci 1(3):200-208. https ://doi.org/10.111 1/j.1752-8062.2008.00053 .x
  170. van der Made TK, Fedecostante M, Scotcher D, et al. (2019) Quantita- tive translation of microfluidic transporter in vitro data to in vivo reveals impaired albumin-facilitated indoxyl sulfate secretion in chronic kidney disease. Mol Pharm. https ://doi.org/10.1021/acs. molph armac eut.9b006 81
  171. van Genderen AM, Jansen J, Cheng C, Vermonden T, Masereeuw R (2018) renal tubular-and vascular basement membranes and their mimicry in engineering vascularized kidney tubules. Adv Healthc Mater 7(19):e1800529. https ://doi.org/10.1002/ adhm.20180 0529
  172. Vervaet BA, D'Haese PC, Verhulst A (2017) Environmental toxin- induced acute kidney injury. Clin Kidney J 10:747-758. https :// doi.org/10.1093/ckj/sfx06 2
  173. Vlasakova K, Erdos Z, Troth SP et al (2014) Evaluation of the relative performance of 12 urinary biomarkers for renal safety across 22 rat sensitivity and specificity studies. Toxicol Sci Off J Soc Toxicol 138(1):3-20. https ://doi.org/10.1093/toxsc i/kft33 0
  174. Vriend J, Nieskens TTG, Vormann MK et al (2018) screening of drug-transporter interactions in a 3D microfluidic renal proxi- mal tubule on a chip. AAPS J 20:87. https ://doi.org/10.1208/ s1224 8-018-0247-0
  175. Walshe CM, Odejayi F, Ng S, Marsh B (2009) Urinary glutathione S-transferase as an early marker for renal dysfunction in patients admitted to intensive care with sepsis. Crit Care Resusc J Aus- tralas Acad Crit Care Med 11(3):204-209
  176. Wang JJ, Chi NH, Huang TM et al (2018) Urinary biomarkers pre- dict advanced acute kidney injury after cardiovascular surgery. Crit Care (London, England) 22(1):108. https ://doi.org/10.1186/ s1305 4-018-2035-8
  177. Weber EJ, Chapron A, Chapron BD et al (2016) Development of a microphysiological model of human kidney proximal tubule function. Kidney Int 90(3):627-637. https ://doi.org/10.1016/j. kint.2016.06.011
  178. Weber EJ, Himmelfarb J, Kelly EJ (2017) Concise review: current and emerging biomarkers of nephrotoxicity. Curr Opin Toxicol 4:16-21. https ://doi.org/10.1016/j.cotox .2017.03.002
  179. Wei Z, Amponsah PK, Al-Shatti M, Nie Z, Bandyopadhyay BC (2012) Engineering of polarized tubular structures in a microfluidic device to study calcium phosphate stone formation. Lab Chip 12(20):4037-4040. https ://doi.org/10.1039/c2lc4 0801e
  180. Widemann BC, Adamson PC (2006) Understanding and managing methotrexate nephrotoxicity. Oncologist 11(6):694-703. https ://doi.org/10.1634/theon colog ist.11-6-694
  181. Wieser M, Stadler G, Jennings P et al (2008) hTERT alone immor- talizes epithelial cells of renal proximal tubules without chang- ing their functional characteristics. Am J Physiol Renal Physiol 295(5):F1365-F1375. https ://doi.org/10.1152/ajpre nal.90405 .2008
  182. Wilmer MJ, Saleem MA, Masereeuw R et al (2010) Novel condition- ally immortalized human proximal tubule cell line express- ing functional influx and efflux transporters. Cell Tissue Res 339:449-457. https ://doi.org/10.1007/s0044 1-009-0882-y Wilmer MJ, Ng CP, Lanz HL, Vulto P, Suter-Dick L, Masereeuw R (2016) Kidney-on-a-chip technology for drug-induced nephro- toxicity screening. Trends Biotechnol 34:156-170. https ://doi. org/10.1016/j.tibte ch.2015.11.001
  183. Wilmes A, Bielow C, Ranninger C et al (2015) Mechanism of cisplatin proximal tubule toxicity revealed by integrating transcriptom- ics, proteomics, metabolomics and biokinetics. Toxicol In Vitro 30:117-127. https ://doi.org/10.1016/J.TIV.2014.10.006
  184. Wnorowski A, Yang H, Wu JC (2018) Progress, obstacles, and limita- tions in the use of stem cells in organ-on-a-chip models. Adv Drug Deliv Rev. https ://doi.org/10.1016/j.addr.2018.06.001
  185. Wu C-Y, Yang H-Y, Chien H-P, Tseng M-H, Huang J-L (2018) Urinary clusterin-a novel urinary biomarker associated with pediatric lupus renal histopathologic features and renal survival. Pedi- atr Nephrol 33(7):1189-1198. https ://doi.org/10.1007/s0046 7-018-3924-4
  186. Xia Y, Sancho-Martinez I, Nivet E, Rodriguez Esteban C, Campistol JM, Izpisua Belmonte JC (2014) The generation of kidney orga- noids by differentiation of human pluripotent cells to ureteric bud progenitor-like cells. Nat Protoc 9:2693-2704. https ://doi. org/10.1038/nprot .2014.182
  187. Xiao L, Liu Y-P, Xiao C-X, Ren J-L, Guleng B (2014) Serum TFF3 may be a pharamcodynamic marker of responses to chemother- apy in gastrointestinal cancers. BMC Clin Pathol 14:26. https :// doi.org/10.1186/1472-6890-14-26
  188. Xie Y, Sakatsume M, Nishi S, Narita I, Arakawa M, Gejyo F (2001) Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 60(5):1645-1657. https ://doi.org/10.10 46/j.1523-1755.2001.00032 .x
  189. Xie HG, Wang SK, Cao CC, Harpur E (2013) Qualified kidney bio- markers and their potential significance in drug safety evalua- tion and prediction. Pharmacol Ther 137(1):100-107. https ://doi. org/10.1016/j.pharm thera .2012.09.004
  190. Yildiz C, Ozsurekci Y, Gucer S, Cengiz AB, Topaloglu R (2013) Acute kidney injury due to acyclovir. CEN Case Rep 2(1):38-40. https ://doi.org/10.1007/s1373 0-012-0035-0
  191. Yin C, Wang N (2016) Kidney injury molecule-1 in kidney disease. Ren Fail 38(10):1567-1573. https ://doi.org/10.1080/08860 22x.2016.11938 16
  192. Yu Y, Jin H, Holder D et al (2010) Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury. Nat Biotechnol 28(5):470-477. https ://doi.org/10.1038/nbt.1624
  193. Yu S-M, Oh JM, Lee J et al (2018) Substrate curvature affects the shape, orientation, and polarization of renal epithelial cells. Acta Biomater 77:311-321. https ://doi.org/10.1016/j.actbi o.2018.07.019
  194. Zajjari Y, Azizi M, Sbitti Y, El Kabbaj D (2017) Nephrotoxicity in a patient treated with pemetrexed. Indian J Nephrol 27(3):243-244. https ://doi.org/10.4103/0971-4065.20240 3
  195. Zazuli Z, Otten LS, Drögemöller BI et al (2019) Outcome definition influences the relationship between genetic polymorphisms of ERCC1, ERCC2, SLC22A2 and cisplatin nephrotoxicity in adult testicular cancer patients. Genes (Basel) 10(5):364. https ://doi. org/10.3390/genes 10050 364
  196. Zhao P, Zhang L, Grillo J et al (2011) Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review. Clin Pharmacol Ther 89(2):259-267. https :// doi.org/10.1038/clpt.2010.298
  197. Zhao K-W, Murray EJB, Murray SS (2017) HK2 proximal tubule epithelial cells synthesize and secrete plasma proteins predomi- nantly through the apical surface. J Cell Biochem 118:924-933. https ://doi.org/10.1002/jcb.25786

Related papers

Drug-Induced Nephrotoxicity Assessment in 3D Cellular Models
Ivan Pachon

Micromachines

The kidneys are often involved in adverse effects and toxicity caused by exposure to foreign compounds, chemicals, and drugs. Early predictions of these influences are essential to facilitate new, safe drugs to enter the market. However, in current drug treatments, drug-induced nephrotoxicity accounts for 1/4 of reported serious adverse reactions, and 1/3 of them are attributable to antibiotics. Drug-induced nephrotoxicity is driven by multiple mechanisms, including altered glomerular hemodynamics, renal tubular cytotoxicity, inflammation, crystal nephropathy, and thrombotic microangiopathy. Although the functional proteins expressed by renal tubules that mediate drug sensitivity are well known, current in vitro 2D cell models do not faithfully replicate the morphology and intact renal tubule function, and therefore, they do not replicate in vivo nephrotoxicity. The kidney is delicate and complex, consisting of a filter unit and a tubular part, which together contain more than 20 di...

View PDFchevron_right
Bioengineered 3D Human Kidney Tissue, a Platform for the Determination of Nephrotoxicity
Adrian Roth

PLoS ONE, 2013

The staggering cost of bringing a drug to market coupled with the extremely high failure rate of prospective compounds in early phase clinical trials due to unexpected human toxicity makes it imperative that more relevant human models be developed to better predict drug toxicity. Drug-induced nephrotoxicity remains especially difficult to predict in both preclinical and clinical settings and is often undetected until patient hospitalization. Current pre-clinical methods of determining renal toxicity include 2D cell cultures and animal models, both of which are incapable of fully recapitulating the in vivo human response to drugs, contributing to the high failure rate upon clinical trials. We have bioengineered a 3D kidney tissue model using immortalized human renal cortical epithelial cells with kidney functions similar to that found in vivo. These 3D tissues were compared to 2D cells in terms of both acute (3 days) and chronic (2 weeks) toxicity induced by Cisplatin, Gentamicin, and Doxorubicin using both traditional LDH secretion and the pre-clinical biomarkers Kim-1 and NGAL as assessments of toxicity. The 3D tissues were more sensitive to drug-induced toxicity and, unlike the 2D cells, were capable of being used to monitor chronic toxicity due to repeat dosing. The inclusion of this tissue model in drug testing prior to the initiation of phase I clinical trials would allow for better prediction of the nephrotoxic effects of new drugs.

View PDFchevron_right
A-1 Comparing 2 D Kidney Cell and 3 D Kidney Organoid Cultures in Drug Toxicity Assays
Olaf Hardt

2015

Many new 3-D cell culture models seek to preserve in vivo-like organization within tissue-like or organoid constructs to elicit more relevant pharmacological toxicity and toxicity marker up-regulation.(Grainger, Adv. Drug Del. Rev, 69:vii-xi (2014) Critical receptors and metabolic pathways responsible for prodrug or parent drug transformations to active drug forms are often missing in cell line assays. Validation of 3-D tissue culture models against 2D ‘gold standard cultures’ for in vitro toxicological evaluation in drug testing should compare clinical toxicity biomarkers. In vitro 3-D organoid models developed to date often confirm that systems with native cellular interactions better ensure biological requirements for sustaining tissue relevant responses to drugs. These 3-D cell culture models can yield better data quality, more accurate, tissue-specific information to significantly improve the technical output, predictive value, and translation be tween in v i t ro , an ima l , ...

View PDFchevron_right
Kidney-based in vivo model for drug-induced nephrotoxicity testing
Yuan-yow Chiou

Scientific Reports

The need is critical and urgent for a real-time, highly specific, and sensitive acute kidney injury biomarker. This study sought to establish a sensitive and specific Miox-NanoLuc transgenic mouse for early detection of drug-induced nephrotoxicity. We generated Miox-NanoLuc transgenic mice with kidney-specific NanoLuc overexpression. Our data showed that Miox-NanoLuc-produced luminescence was kidney-specific and had good stability at room temperature, 4 °C, − 20 °C, and repeated freeze–thaw cycles. Serum levels of BUN and creatinine were significantly increased at day 2 or 3 in cisplatin-treated mice and at day 5 in aristolochic acid (AAI)-treated mice. Particularly, the serum and urine Miox-NanoLuc luminescence levels were significantly increased at day 1 in cisplatin-treated mice and at day 3 in AAI-treated mice. Renal pathological analysis showed that the kidney sections of cisplatin-treated mice at day 5 and AAI-treated mice at day 13 showed cytolysis and marked vacuolization of...

View PDFchevron_right
Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment
Ali Gholami Mehr

Integrative Biology, 2013

Kidney toxicity is one of the most frequent adverse events reported during drug development. The lack of accurate predictive cell culture models and the unreliability of animal studies have created a need for better approaches to recapitulate kidney function in vitro. Here, we describe a microfluidic device lined by living human kidney epithelial cells exposed to fluidic flow that mimics key functions of the human kidney proximal tubule. Primary kidney epithelial cells isolated from human proximal tubule are cultured on the upper surface of an extracellular matrix-coated, porous, polyester membrane that splits the main channel of the device into two adjacent channels, thereby creating an apical 'luminal' channel and a basal 'interstitial' space. Exposure of the epithelial monolayer to an apical fluid shear stress (0.2 dyne cm À2) that mimics that found in living kidney tubules results in enhanced epithelial cell polarization and primary cilia formation compared to traditional Transwell culture systems. The cells also exhibited significantly greater albumin transport, glucose reabsorption, and brush border alkaline phosphatase activity. Importantly, cisplatin toxicity and Pgp efflux transporter activity measured on-chip more closely mimic the in vivo responses than results obtained with cells maintained under conventional culture conditions. While past studies have analyzed kidney tubular cells cultured under flow conditions in vitro, this is the first report of a toxicity study using primary human kidney proximal tubular epithelial cells in a microfluidic 'organ-on-a-chip' microdevice. The in vivo-like pathophysiology observed in this system suggests that it might serve as a useful tool for evaluating human-relevant renal toxicity in preclinical safety studies. Insight, innovation, integration The lack of accurate predictive cell culture models and the unreliability of animal studies have created a need for alternative in vitro models for human kidney tubular cells and their function. Here, we combine microengineering, cell biology and physiological approaches to create a microfluidic device lined by living human kidney proximal tubular epithelial cells, and show that it exhibits in vivo-like proximal tubular morphology, function and drug toxicity responses when exposed to apical fluid shear stress. Because this kidney tubule microdevice mimics in vivo-like pathophysiology, it could prove useful for investigating humanrelevant renal toxicities during drug development.

View PDFchevron_right

Related topics

  • Pharmacology
  • Medicine
  • Pharmacology and pharmaceutical ...

    • Cited by

    Sirtuins play critical and diverse roles in acute kidney injury
    Eric Goetzman

    Pediatric Nephrology

    Acute kidney injury (AKI) is an extremely common medical affliction affecting both adult and pediatric patients resulting from hypoxic, nephrotoxic, and septic insults affecting approximately 20% of all hospital patients and up to 50% of patients in the intensive care unit. There are currently no therapeutics for patients who suffer AKI. Much recent work has focused on designing and implementing therapeutics for AKI. This review focuses on a family of enzymes known as sirtuins that play critical roles in regulating many cellular and biological functions. There are 7 mammalian sirtuins (SIRT1-7) that play roles in regulating the acylation of a wide variety of pathways. Furthermore, all but one of the mammalian sirtuins have been shown to play critical roles in mediating AKI based on preclinical studies. These diverse enzymes show exciting potential for therapeutic manipulation. This review will focus on the specific roles of each of the investigated sirtuins and the potential for manipulation of the various sirtuins and their effector pathways in mediating kidney injury.

    View PDFchevron_right
    The Mechanism of Drug Nephrotoxicity and the Methods for Preventing Kidney Damage
    Ewa Kwiatkowska

    International Journal of Molecular Sciences

    Acute kidney injury (AKI) is a global health challenge of vast proportions, as approx. 13.3% of people worldwide are affected annually. The pathophysiology of AKI is very complex, but its main causes are sepsis, ischemia, and nephrotoxicity. Nephrotoxicity is mainly associated with the use of drugs. Drug-induced AKI accounts for 19–26% of all hospitalized cases. Drug-induced nephrotoxicity develops according to one of the three mechanisms: (1) proximal tubular injury and acute tubular necrosis (ATN) (a dose-dependent mechanism), where the cause is related to apical contact with drugs or their metabolites, the transport of drugs and their metabolites from the apical surface, and the secretion of drugs from the basolateral surface into the tubular lumen; (2) tubular obstruction by crystals or casts containing drugs and their metabolites (a dose-dependent mechanism); (3) interstitial nephritis induced by drugs and their metabolites (a dose-independent mechanism). In this article, the m...

    View PDFchevron_right
    Consequences of Both Coxsackievirus B4 and Type 1 Diabetes on Female Non-Obese Diabetic Mouse Kidneys
    Kelly McCall

    Microorganisms

    Despite the 2019 Executive Order on Advancing American Kidney Health Initiative, kidney disease has moved up in rank from the 9th to the 8th leading cause of death in the United States. A recent push in the field of nephrology has been to identify molecular markers and/or molecular profiles involved in kidney disease process or injury that can help identify the cause of injury and predict patient outcomes. While these studies have had moderate success, they have not yet considered that many of the health conditions that cause kidney disease (diabetes, hypertension, etc.) can also be caused by environmental factors (such as viruses), which in and of themselves can cause kidney disease. Thus, the goal of this study was to identify molecular and phenotypic profiles that can differentiate kidney injury caused by diabetes (a health condition resulting in kidney disease) and coxsackievirus B4 (CVB4) exposure (which can cause diabetes and/or kidney disease), both alone and together. Non-ob...

    View PDFchevron_right
    Drug-Induced Nephrotoxicity Assessment in 3D Cellular Models
    Ivan Pachon

    Micromachines

    The kidneys are often involved in adverse effects and toxicity caused by exposure to foreign compounds, chemicals, and drugs. Early predictions of these influences are essential to facilitate new, safe drugs to enter the market. However, in current drug treatments, drug-induced nephrotoxicity accounts for 1/4 of reported serious adverse reactions, and 1/3 of them are attributable to antibiotics. Drug-induced nephrotoxicity is driven by multiple mechanisms, including altered glomerular hemodynamics, renal tubular cytotoxicity, inflammation, crystal nephropathy, and thrombotic microangiopathy. Although the functional proteins expressed by renal tubules that mediate drug sensitivity are well known, current in vitro 2D cell models do not faithfully replicate the morphology and intact renal tubule function, and therefore, they do not replicate in vivo nephrotoxicity. The kidney is delicate and complex, consisting of a filter unit and a tubular part, which together contain more than 20 di...

    View PDFchevron_right
    Applications of Polymers for Organ-on-Chip Technology in Urology
    Eliza Simsensohn

    Polymers

    Organ-on-chips (OOCs) are microfluidic devices used for creating physiological organ biomimetic systems. OOC technology brings numerous advantages in the current landscape of preclinical models, capable of recapitulating the multicellular assemblage, tissue–tissue interaction, and replicating numerous human pathologies. Moreover, in cancer research, OOCs emulate the 3D hierarchical complexity of in vivo tumors and mimic the tumor microenvironment, being a practical cost-efficient solution for tumor-growth investigation and anticancer drug screening. OOCs are compact and easy-to-use microphysiological functional units that recapitulate the native function and the mechanical strain that the cells experience in the human bodies, allowing the development of a wide range of applications such as disease modeling or even the development of diagnostic devices. In this context, the current work aims to review the scientific literature in the field of microfluidic devices designed for urology...

    View PDFchevron_right
    580 California St., Suite 400
    San Francisco, CA, 94104
    © 2025 Academia. All rights reserved